Health ❯ Healthcare ❯ Clinical Trials

Regulatory Approval

Lecanemab Drug Development FDA Trials EU Drug Approval Medical Innovations Drug Development Pipeline FDA Processes FDA Process FDA Submission DCGI Clinical Trial Waivers

Agios’ Sickle Cell Pill Lifts Hemoglobin but Misses Pain-Crisis Goal in Phase 3

The mixed efficacy leaves mitapivat’s expansion prospects uncertain during an FDA review in beta thalassemia that targets a Dec. 7 decision.

UK Approves Once-Every-Four-Weeks IV Maintenance Dosing for Leqembi in Early Alzheimer’s

Indomo's ClearPen, an At-Home Acne Steroid Injector, Set for Phase 2 Trial Next Year

Hot-Glue-Gun Device 3D-Prints Bone Implants in Surgery With Promising Rabbit Results